secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOVIE INC. (BIVI)
CIK:        0001580149
Form:       8-K
Filed at:   2022-12-23T23:59:59+00:00
Accession:  0001520138-22-000583
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioVie files prospectus supplement for $17.5M ATM offering; already raised $29M
-------------------------------------------------------------------------------

- Filed prospectus supplement on Dec 23, 2022 for up to $17.5M in Class A common stock sales.
- As of Dec 20, 2022, issued 3,709,509 shares under existing ATM for net proceeds of $29.0M.
- Sales agents are Cantor Fitzgerald & Co. and B. Riley Securities, Inc.
- New shares offered under Registration Statement No. 333-252386 via the August 31, 2022 Sales Agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1580149/000152013822000583/0001520138-22-000583-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1580149/000152013822000583/bivi-20221223_8k.htm
  HTML page:      https://secwatch.observer/filing/0001520138-22-000583

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer